Reports

Sale

Enzyme-linked Immunosorbent Assays (ELISAs) Market

Global Enzyme-linked Immunosorbent Assays (ELISAs) Market: By Test Type: Sandwich ELISA, Competitive ELISA, Indirect ELISA, Multiple and Portable ELISA, Others; By Application: Cancer, Protein Quantification, Immunology, Inflammation, Infectious Diseases, Other; Regional Analysis; Market Dynamics; Competitive Landscape; 2024-2032

Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Outlook

The global enzyme-linked immunosorbent assays (ELISAs) market is expected to grow at a CAGR of 3.0% during the period 2024-2032. The global market is expected to be driven by applications of enzyme-linked immunosorbent assays (ELISAs) in multiple settings, including rapid antibody screening tests for HIV, recognition of other viruses, fungi, bacteria, food allergens, autoimmune diseases, blood typing, presence of the pregnancy hormone hCG, forensic toxicology, laboratory and clinical research, and several other diagnostic settings. ELISAs are sensitive, precise, and inexpensive. These aspects are expected to drive the global market. North America, Europe and Asia are likely to be key markets.

 

enzyme linked immunosorbent assays elisas market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Market Likely to be Driven by Applications in Various Settings

Enzyme-linked immunosorbent assay (ELISA) is a labelled immunoassay accepted as the gold standard of immunoassays. The immunological test is very sensitive and is employed to detect and quantify substances, including antibodies, antigens, proteins, glycoproteins, and hormones. There are three common variations of enzyme-linked immunosorbent assays (ELISAs) - double antibody sandwich ELISA, indirect ELISA, and competitive ELISA; these have a broad variety of applications, including clinical, forensic and food research. Recognition of cancer biomarkers for early cancer detection is a task continually being researched and developed. Enzyme-linked immunosorbent assay (ELISA) based techniques are available and employed clinically for testing for early phases of cancer (including breast and ovarian cancer).

Enzyme-linked immunosorbent assay (ELISA) is also used to determine concentrations of illegal drugs, like cannabinoids, amphetamines, opiates, cocaine, benzodiazepines, and methadone, in urine samples. Further, the method may be used to monitor levels of pharmaceutical drug concentrations in individuals under treatment, for instance, antidrug antibodies in rheumatoid arthritis and inflammatory bowel disease. Enzyme-linked immunosorbent assay (ELISA) is also usually employed to test for the detection of hormone human chorionic gonadotrophin (hCG) in urine (which is present in higher amounts in pregnant women), thus enabling easy access and home testing capabilities.

 

Global Market Likely to be Driven by Inexpensive and Precise Solutions Offered by Enzyme-linked Immunosorbent Assays (ELISAs)

Detection of platelet antibodies in serum is employed to recognize individuals suffering from disorders such as idiopathic thrombocytopenic purpura and systemic lupus erythematosus. These tests use alkaline phosphatase (enzyme), labelled with anti-human lgG. While being a less expensive and complicated method for detection of platelet antibodies, enzyme-linked immunosorbent assay (ELISA) is also reported to offer more than other generally employed tests, like the lymphocytotoxicity (LCT) and platelet immunofluorescence test (PIIFT). These aspects are expected to boost the global enzyme-linked immunosorbent assays (ELISAs) market.

In the food industry, enzyme-linked immunosorbent assay (ELISA) is popularly used to determine the presence of allergens for legally required ingredient labelling. The application benefits significantly from the sensitivity of ELISA and is able to detect levels of potential food allergen contaminants at concentrations on lower parts per million (ppm) scale. Further, it may be used to test for oils and other substances such as egg whites or milk, which other methods such as PCR are unable to detect.

 

Important Applications for Developing Countries Likely to Stimulate Market Growth

The global enzyme-linked immunosorbent assays (ELISAs) market is expected to be stimulated by an important application – detection of viruses – which is especially useful for developing countries with high infection rates. The method can reach the most susceptible groups with on-site testing capabilities and prompt results, enabling opportunistic testing.

 

Market Segmentation

 

enzyme linked immunosorbent assays elisas market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By test type, the market is segmented into:

  • Sandwich ELISA
  • Competitive ELISA
  • Indirect ELISA
  • Multiple and Portable ELISA
  • Others

By application, the market is divided into:

  • Cancer
  • Protein Quantification
  • Immunology
  • Inflammation
  • Infectious Diseases
  • Other

By region, the market is classified into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

enzyme linked immunosorbent assays elisas market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Key Industry Players in the Market

The report presents a detailed analysis of the following key players in the global enzyme-linked immunosorbent assays (ELISAs) market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • BioLegend, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzo Life Sciences, Inc.
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Test Type
  • Application
  • Region
Breakup by Test Type
  • Sandwich ELISA
  • Competitive ELISA
  • Indirect ELISA
  • Multiple and Portable ELISA
  • Others
Breakup by Application
  • Cancer
  • Protein Quantification
  • Immunology
  • Inflammation
  • Infectious Diseases
  • Other
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • BioLegend, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzo Life Sciences, Inc.
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Enzyme-linked Immunosorbent Assays Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market (2017-2023) 
    8.3    Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast (2024-2032)
    8.4    Global Enzyme-linked Immunosorbent Assays (ELISAs) Market by Test Type
        8.4.1    Sandwich ELISA
            8.4.1.1    Historical Trend (2017-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Competitive ELISA
            8.4.2.1    Historical Trend (2017-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Indirect ELISA
            8.4.3.1    Historical Trend (2017-2023)
            8.4.3.2    Forecast Trend (2024-2032)
        8.4.4    Multiple and Portable ELISA
            8.4.4.1    Historical Trend (2017-2023)
            8.4.4.2    Forecast Trend (2024-2032)
        8.4.5    Others
    8.5    Global Enzyme-linked Immunosorbent Assays (ELISAs) Market by Application
        8.5.1    Cancer
            8.5.1.1    Historical Trend (2017-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Protein Quantification
            8.5.2.1    Historical Trend (2017-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Immunology
            8.5.3.1    Historical Trend (2017-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Inflammation
            8.5.4.1    Historical Trend (2017-2023)
            8.5.4.2    Forecast Trend (2024-2032)
        8.5.5    Infectious Diseases
            8.5.5.1    Historical Trend (2017-2023)
            8.5.5.2    Forecast Trend (2024-2032)
        8.5.6    Other   
    8.6    Global Enzyme-linked Immunosorbent Assays (ELISAs) Market by Region
        8.6.1    North America
            8.6.1.1    Historical Trend (2017-2023) 
            8.6.1.2    Forecast Trend (2024-2032)
        8.6.2    Europe
            8.6.2.1    Historical Trend (2017-2023) 
            8.6.2.2    Forecast Trend (2024-2032)
        8.6.3    Asia Pacific
            8.6.3.1    Historical Trend (2017-2023) 
            8.6.3.2    Forecast Trend (2024-2032)
        8.6.4    Latin America
              8.6.4.1    Historical Trend (2017-2023) 
              8.6.4.2    Forecast Trend (2024-2032)
        8.6.5    Middle East and Africa
            8.6.5.1    Historical Trend (2017-2023) 
            8.6.5.2    Forecast Trend (2024-2032)
9    North America Enzyme-linked Immunosorbent Assays (ELISAs) Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2017-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2017-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Enzyme-linked Immunosorbent Assays (ELISAs) Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2017-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2017-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2017-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2017-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5   Others
11    Asia Pacific Enzyme-linked Immunosorbent Assays (ELISAs) Market Analysis
    11.1    China
        11.1.1    Historical Trend (2017-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2017-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2017-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2017-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2017-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Enzyme-linked Immunosorbent Assays (ELISAs) Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2017-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2017-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2017-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Enzyme-linked Immunosorbent Assays (ELISAs) Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2017-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2017-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2017-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2017-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Thermo Fisher Scientific Inc.
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Becton, Dickinson and Company
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    BioLegend, Inc.
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Bio-Rad Laboratories, Inc.
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Enzo Life Sciences, Inc.
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Others
16    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Enzyme-linked Immunosorbent Assays (ELISAs) Market: Key Industry Highlights, 2017 and 2032
2.    Global Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Test Type (USD Million), 2017-2023
3.    Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Test Type (USD Million), 2024-2032
4.    Global Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Application (USD Million), 2017-2023
5.    Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Application (USD Million), 2024-2032
6.    Global Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Region (USD Million), 2017-2023
7.    Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Region (USD Million), 2024-2032
8.    North America Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2023
9.    North America Enzyme-linked Immunosorbent Assays (ELISA) Market Forecast: Breakup by Country (USD Million), 2024-2032
10.    Europe Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2023
11.    Europe Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Country (USD Million), 2024-2032
12.    Asia Pacific Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2023
13.    Asia Pacific Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Latin America Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2023
15.    Latin America Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Middle East and Africa Enzyme-linked Immunosorbent Assays (ELISAs) Historical Market: Breakup by Country (USD Million), 2017-2023
17.    Middle East and Africa Enzyme-linked Immunosorbent Assays (ELISAs) Market Forecast: Breakup by Country (USD Million), 2024-2032
18.    Global Enzyme-linked Immunosorbent Assays (ELISAs) Market Structure

Key Questions Answered in the Report

The global enzyme-linked immunosorbent assays (ELISAs) market is projected to grow at a CAGR of 3.0% between 2024 and 2032.

The major drivers of the market include the increasing demand for cost-effective diagnostic tools, growing applications of ELISA in multiple settings, such as rapid antibody screening tests for HIV, rising need for frequent diagnostic testing, and increasing geriatric population.

The growing applications of ELISA in oncology and the rising incidence of infectious diseases and cancer are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Based on test type, the market is segmented into sandwich ELISA, competitive ELISA, indirect ELISA, multiple and portable ELISA, among others.

The significant applications of the market include cancer, protein quantification, immunology, inflammation, and infectious diseases, among others.

The major players in the industry are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, BioLegend, Inc., Bio-Rad Laboratories, Inc., and Enzo Life Sciences, Inc., among others.

Analyst Review

The global enzyme-linked immunosorbent assays (ELISAs) market was driven by the rising incidence of infectious diseases and cancer in the historical period. Aided by the growing applications of ELISA in multiple settings, such as rapid antibody screening tests for HIV and rising need for frequent diagnostic testing, the market is expected to grow at a CAGR of 3.0% in the forecast period of 2024-2032.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on test type, the market is segmented into sandwich ELISA, competitive ELISA, indirect ELISA, multiple and portable ELISA, among others. The significant applications of the market are cancer, protein quantification, immunology, inflammation, and infectious diseases, among others. The major regional markets for enzyme-linked immunosorbent assays (ELISAs) are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The major players in the market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, BioLegend, Inc., Bio-Rad Laboratories, Inc., and Enzo Life Sciences, Inc., among others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER